Advanced Heart Failure and Transplant Cardiology · Beverly Hills, CA
NPI
1972607216
Since 2006
Specialty
Advanced Heart Failure and Transplant Cardiology
Code 207RA0001X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
8536 Wilshire Blvd # 302
Beverly Hills, CA, 90211
Phone (310) 248-8300
Groups this clinician bills Medicare through
Medicare paid, 2024
$361K
3,939 services
Medicare patients, 2024
1,719
Average age 74
Drug cost, 2024
$10.9M
8,631 prescriptions
Company payments, 2025
$23.85
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Michelle Kittleson was code 93306 (echocardiography (tte/tee)), 886 times for 559 patients. In total Michelle Kittleson billed 3,939 services in 39 codes, and Medicare paid $361K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-03-01.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 93306 Echocardiography (TTE/TEE) | Facility | 886 | 559 | $51.96 | $46K |
| 93306 Echocardiography (TTE/TEE) | Office | 618 | 560 | $165.70 | $102K |
| 99214 Office E&M - Established | Facility | 420 | 263 | $75.28 | $32K |
| 93351 Echocardiography (TTE/TEE) | Office | 315 | 309 | $188.83 | $59K |
| 93325 Echocardiography (TTE/TEE) | Office | 281 | 275 | $21.70 | $6,099 |
| 93320 Echocardiography (TTE/TEE) | Office | 276 | 271 | $45.85 | $13K |
| 99233 Hospital E&M - Subsequent | Facility | 219 | 60 | $98.27 | $22K |
| 99214 Office E&M - Established | Office | 194 | 186 | $102.71 | $20K |
| 99215 Office E&M - Established | Facility | 135 | 98 | $112.56 | $15K |
| 99215 Office E&M - Established | Office | 60 | 42 | $147.49 | $8,850 |
| 99205 Office E&M - New | Facility | 49 | 49 | $144.43 | $7,077 |
| 99204 Office E&M - New | Office | 46 | 46 | $130.50 | $6,003 |
| 99443 Telephone Services | Office | 41 | 32 | $105.24 | $4,315 |
| 99443 Telephone Services | Facility | 40 | 35 | $81.45 | $3,258 |
| 93356 Echocardiography (TTE/TEE) | Office | 36 | 34 | $33.27 | $1,198 |
By year: 2022 $324K for 3,518 services; 2023 $324K for 3,532 services; 2024 $361K for 3,939 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 32 | 25 | $8.65 | $277 |
Medicare prescription drug claims, 2024
In 2024, the drug Michelle Kittleson prescribed most often to Medicare patients was Tacrolimus, with 607 prescriptions and refills. In total Michelle Kittleson wrote 8,631 Medicare prescriptions that cost $10.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Tacrolimus Generic | 607 | 1,427 | 168 | $129K |
| Pravastatin Sodium Generic | 606 | 1,574 | 191 | $6,880 |
| Prednisone Generic | 586 | 1,408 | 178 | $5,126 |
| Amlodipine Besylate Generic | 547 | 1,496 | 177 | $4,131 |
| Rosuvastatin Calcium Generic | 391 | 1,018 | 126 | $5,920 |
| Mycophenolate Mofetil Generic | 379 | 904 | 111 | $49K |
| Vyndamax Tafamidis | 356 | 372 | 45 | $8.1M |
| Pantoprazole Sodium Generic | 280 | 617 | 95 | $3,037 |
| Losartan Potassium Generic | 253 | 727 | 81 | $3,115 |
| Eliquis Apixaban | 250 | 482 | 67 | $277K |
| Metoprolol Succinate Generic | 233 | 604 | 69 | $2,931 |
| Lisinopril Generic | 210 | 533 | 58 | $1,050 |
| Sirolimus Generic | 209 | 486 | 47 | $81K |
| Atorvastatin Calcium Generic | 203 | 580 | 67 | $2,315 |
| Furosemide Generic | 201 | 471 | 75 | $1,278 |
Brand drugs: 1,320 claims; generic drugs: 7,294 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Michelle Kittleson $23.85 ($23.85 in general payments such as food, travel and fees) from 1 company. The largest payer was Abbott Laboratories with $23.85.
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories ABT | 1 | $23.85 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.